NHIA honors Masood’s advocacy 

ALEXANDRIA, Va. – The National Home Infusion Association has announced that Sohail Masood, PharmD, is the recipient of the 2022 Gene Graves Lifetime Achievement Award. The award, which is the highest honor that NHIA bestows on a member of the home and alternate site infusion profession, is given to an individual who has dedicated significant time, energy and resources to advocating on behalf of patients and the industry. “I am humbled and honored that NHIA selected me for the most prestigious Gene Graves Award,” said Dr. Masood. “For 35 years I have been involved in the home infusion industry in one way or another and it has been rewarding as I have been able to make a difference in so many of my patients’ lives.”  Dr. Masood will receive the award at NHIA’s 2022 Annual Conference on March 15. Masood is the founder and CEO of KabaFusion, which has 22 pharmacies strategically located across the country. He was instrumental in establishing home infusion as a preferred site of care for IVIG infusion by educating physicians on its clinical benefits in neuromuscular disorders. He has contributed to the growing body of knowledge through research that has led to many new uses for IVIG, including Multifocal Motor Neuropathy (MMN), Stiff Person Syndrome (SPS), Small Fiber Neuropathy and other diseases. In 2001, Dr. Masood assisted a landmark study of IVIG use in Stiff Person Syndrome by donating product that was in severe shortage to allow the National Institutes of Health (NIH) to complete the project. More recently, his non-profit, Dysimmune Diseases Foundation, initiated novel research on the use of IVIG in Diabetic Neuropathy.